NYSE

Updated Oct 30, 7:59 PM ET

BHVN

Biohaven Ltd.
$15.42CS band Weak

−$1.07 (6.49%) Fri · Closed $15.42

$0.00 (0.00%) ☾ After Hours

Oct 30, 7:59 PM ET

About BHVN

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Why it moved

Moved with Pharmaceuticals peers: SDGR −9.50% · BHC −7.97% · PTCT −6.97%

From market data · Not investment advice

Sign up free to see this.

Daily pricesFundamentals

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

Votes and Bull · Bear posts, 24h. At least 5 are needed.

How do you feel about BHVN?

Board · 0 threads

Open board ›

Community opinions, not advice. Posts with a target get a receipt. How receipts work ›